Аннотация
NVP-AUY922, a novel inhibitor of Hsp90, was shown to enhance the effect of
ionizing radiation (IR) on tumor cells under normoxic conditions. Since low
oxygen tension is a common feature of solid tumors, we explore in the present
study the impact of hypoxia on the combined treatment of lung carcinoma A549 and
glioblastoma SNB19 cell lines with NVP-AUY922 and IR. Cellular analysis included
the colony-forming ability, expression of CAIX, Hsp90, Hsp70, Raf-1, Akt, cell
cycle progression and associated proteins, as well as DNA damage measured by
histone gammaH2AX. The clonogenic assay revealed that in both cell lines
NVP-AUY922 enhanced the radiotoxicity under hypoxic exposure to a level similar
to that observed under oxic conditions. Irrespective of oxygen supply during drug
treatment, NVP-AUY922 also reduced the expression of anti-apoptotic proteins
Raf-1 and Akt. As judged by the levels of histone gammaH2AX, drug-treated hypoxic
cells exhibited a lower repair rate of DNA double-strand breaks than normoxic
cells. The drug-IR mediated changes in the cell cycle, i.e., S-phase depletion
and G 2/M arrest, developed not directly during hypoxic exposure but first upon
24 h reoxygenation. Under both oxygen tensions, Hsp90 inhibition downregulated
the cell cycle-associated proteins, Cdk1, Cdk4 and pRb. The finding that
NVP-AUY922 can enhance the in vitro radiosensitivity of hypoxic tumor cells may
have implications for the combined modality treatment of solid tumors.
Пользователи данного ресурса
Пожалуйста,
войдите в систему, чтобы принять участие в дискуссии (добавить собственные рецензию, или комментарий)